Home/Filings/4/0001144204-11-030295
4//SEC Filing

Kogan Yakov 4

Accession 0001144204-11-030295

CIK 0001318641other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:24 PM ET

Size

15.8 KB

Accession

0001144204-11-030295

Insider Transaction Report

Form 4
Period: 2011-05-12
Kogan Yakov
DirectorCOO, Secretary
Transactions
  • Award

    Employee Stock Options (Right to Buy)

    2011-05-12+2,2132,213 total(indirect: By Spouse)
    Exercise: $7.31From: 2011-05-12Exp: 2021-05-11Common Stock (2,213 underlying)
Holdings
  • Employee Stock Options (Right to Buy)

    Exercise: $8.36From: 2007-04-06Exp: 2017-04-05Common Stock (37,500 underlying)
    37,500
  • Employee Stock Options (Right to Buy)

    Exercise: $4.00From: 2008-02-04Exp: 2018-02-03Common Stock (137,250 underlying)
    137,250
  • Employee Stock Options (Right to Buy)

    (indirect: By Spouse)
    Exercise: $3.91From: 2010-08-18Exp: 2020-08-17Common Stock (3,856 underlying)
    3,856
  • Employee Stock Options (Right to Buy)

    (indirect: By Spouse)
    Exercise: $6.09From: 2010-11-17Exp: 2020-11-16Common Stock (4,255 underlying)
    4,255
  • Employee Stock Options (Right to Buy)

    Exercise: $7.16From: 2011-03-21Exp: 2021-03-20Common Stock (149,609 underlying)
    149,609
  • Employee Stock Options (Right to Buy)

    Exercise: $3.44From: 2010-05-18Exp: 2020-05-17Common Stock (105,000 underlying)
    105,000
  • Employee Stock Options (Right to Buy)

    (indirect: By Spouse)
    Exercise: $3.79From: 2010-03-01Exp: 2010-02-02Common Stock (30,000 underlying)
    30,000
  • Employee Stock Options (Right to Buy)

    (indirect: By Spouse)
    Exercise: $7.39From: 2011-03-18Exp: 2021-03-17Common Stock (4,255 underlying)
    2,128
Footnotes (1)
  • [F1]On May 12, 2011, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Leah Brownlee, who was hired as an employee effective March 1,2010. Ms. Brownlee is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1
  • filerCIK 0001370084

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:24 PM ET
Size
15.8 KB